Cramer’s Got His Eye on Allergan, Himax, and These 3 Stocks

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Jim Cramer made the following calls on August 1st, 2013. What do you think about his picks?

Allergan Inc. (NYSE:AGN): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on May 6, 2013. The stock’s 52-week high is $116.45, and its 52-week low is $81.33.

David Pyott, chairman and CEO of Allergan, came on Cramer last night to discuss the state of his business. After beating market expectations for earnings, Pyott noted that while a generic competitor for one of its eye medications looms, the FDA has got it tied up in reviews, meaning less competition for Allergan for the time being.

agn-20130802

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business